CIK: 1704251 - Address: C/o Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT 06510
13 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/7/22 21:18
1/6/22
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOChief CoM.dm00.0002487D
11/26/21 16:33
11/25/21
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOChief CoM.d00.0001335D
1/8/21 20:49
1/6/21
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOChief CoM.d00.0001414D
11/27/20 21:48
11/25/20
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOChief CoM.d00.0001663D
6/12/20 17:19
6/10/20
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOChief CoM.d4839.290521D
6/12/20 17:19
6/10/20
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOChief CoS.d-3,50467.380-52-991D
12/20/19 21:41
12/18/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOCCO-RareM.d00.00011102D
3/14/19 17:51
3/12/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOChief CoM.d939.290102D
3/14/19 17:51
3/12/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOChief CoS.d-50150.110-10-862D
1/14/19 17:50
1/10/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOChief CoM.d989.290112D
1/14/19 17:50
1/10/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOChief CoS.d-39637.670-11-872D
11/2/17 17:55
11/1/17
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOChief CoM.d2799.290302D
11/2/17 17:55
11/1/17
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsTilton JohnCTOChief CoS.d-87829.250-30-952D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact